2006
DOI: 10.1002/biot.200500039
|View full text |Cite
|
Sign up to set email alerts
|

Yeast as a tool to uncover the cellular targets of drugs

Abstract: Knowledge of the spectrum of cellular proteins targeted by experimental therapeutic agents would greatly facilitate drug development. However, identifying the targets of drugs is a daunting challenge. The yeast Saccharomyces cerevisiae is a valuable model organism for human diseases and pathways because it is genetically tractable and shares many functional homolog with humans. In yeast, it is possible to increase or decrease the expression level of essentially every gene and measure changes in drug sensitivit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
50
0

Year Published

2008
2008
2023
2023

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 45 publications
(50 citation statements)
references
References 42 publications
0
50
0
Order By: Relevance
“…While 6-NDA showed similar potency as amphotericin B against C. albicans (IC 50 of 0.28 g/ml for both), its IC 50 against A. fumigatus (0.34 g/ml) was approximately 2.5-fold lower than that of amphotericin B (0.86 g/ml). To determine the cellular effects of 6-NDA in fungal cells, we made use of S. cerevisiae, a well-established model organism that has been successfully utilized in identifying the molecular pathways targeted by antifungal and therapeutic compounds (34,47). A transcriptional profiling study was conducted in S. cerevisiae cells (strain S288C) that were exposed for a period of approximately one doubling time (ϳ4 h) to 2.2 g/ml of 6-NDA, a concentration resulting in 50% growth inhibition.…”
Section: Resultsmentioning
confidence: 99%
“…While 6-NDA showed similar potency as amphotericin B against C. albicans (IC 50 of 0.28 g/ml for both), its IC 50 against A. fumigatus (0.34 g/ml) was approximately 2.5-fold lower than that of amphotericin B (0.86 g/ml). To determine the cellular effects of 6-NDA in fungal cells, we made use of S. cerevisiae, a well-established model organism that has been successfully utilized in identifying the molecular pathways targeted by antifungal and therapeutic compounds (34,47). A transcriptional profiling study was conducted in S. cerevisiae cells (strain S288C) that were exposed for a period of approximately one doubling time (ϳ4 h) to 2.2 g/ml of 6-NDA, a concentration resulting in 50% growth inhibition.…”
Section: Resultsmentioning
confidence: 99%
“…Unfortunately, the protein targets of many compounds are still, in large part, unknown and compound selection remains a challenge. Although several yeast genomics-based strategies have been developed to identify drug targets (Sturgeon et al 2006), each has certain limitations. For example, haploinsufficiency profiling (HIP) represents an assay with the potential to reveal drug targets (Giaever et al 1999(Giaever et al , 2002(Giaever et al , 2004Baetz et al 2004;Lum et al 2004;Doostzadeh et al 2007) but it can fail to identify drug targets if the reduction in gene dose is insufficient.…”
mentioning
confidence: 99%
“…Screening the yeast "disruptome" has proved to be a useful high-throughput functional genomic tool to identify genes involved in responsiveness to drugs (27,44) as well as other phenotypes. Although mutations in genes encoding components involved in the translocation process are plausible candidates to render cells resistant or sensitive to sordarin, it is likely that other mechanisms participate in the response.…”
mentioning
confidence: 99%